CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tasly Pharmaceutical Group Company Limited Company Snapshot
Tasly Pharmaceutical Group Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tasly Pharmaceutical Group Company Limited with three other companies in this sector in China: Shanghai Fosun Pharmaceutical (Group) Company Limited (2016 sales of 14.51 billion Chinese Renmimbi [US$2.13 billion] of which 70% was Pharmaceutical Manufacturing and R&D), Shenzhen Neptunus Bioengineer (13.61 billion Chinese Renmimbi [US$1.99 billion] of which 84% was Pharmaceutical Distribution), and Harbin Pharmaceutical Group Company Limited (14.13 billion Chinese Renmimbi [US$2.07 billion] of which 64% was Medicine Trade).

Sales Analysis. Tasly Pharmaceutical Group Company Limited reported sales of 13.95 billion Chinese Renmimbi (US$2.04 billion) for the year ending December of 2016. This represents an increase of 5.5% versus 2015, when the company's sales were 13.22 billion Chinese Renmimbi. Sales at Tasly Pharmaceutical Group Company Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 112%). Sales of Medicine Commerce saw an increase of 5.3% in 2016, from 6.78 billion Chinese Renmimbi to 7.14 billion Chinese Renmimbi. Not all segments of Tasly Pharmaceutical Group Company Limited experienced an increase in sales in 2016: sales of Pharmaceutical and Medicine Manufacturing fell 73.6% to 1.68 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tasly Pharmaceutical Group Company Limited
  Stock Performance Chart for Tasly Pharmaceutical Group Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (6/16/2017): 39.49
(Figures in Chinese Renmimbi)
1 Week -1.8%   13 Weeks -2.3%  
4 Weeks -0.3%   52 Weeks 13.6%  
 
Tasly Pharmaceutical Group Company Limited Key Data:
  Ticker: 600535 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 13,945,496,952
(Year Ending Jan 2017).
Employees: 10,455
  Currency: Chinese Renmimbi Market Cap: 42,667,992,422
  Fiscal Yr Ends: December Shares Outstanding: 1,080,475,878
  Share Type: A Gu Closely Held Shares: 535,860,908
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.